First participant dosed with novel investigational EBV vaccine targeting multiple viral proteins in Phase I study WESTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO ...
Newcastle Systems, a pioneer in workplace mobility solutions, is pleased to announce it is preparing to exhibit next month at MODEX 2026, taking place in Atlanta, GA, April 13 through 16, at the ...
The big-time BARDA contracts keep rolling in, this time for infectious disease biotech and Merck partner ModeX Therapeutics. The company has hauled in a $168 million contract from the Biomedical ...
Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executed Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results